1 Voriconazole Market Overview 1.1 Product Overview and Scope of Voriconazole 1.2 Voriconazole Segment by Type 1.2.1 Global Voriconazole Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Injection 1.2.3 Freeze-dried Powder 1.3 Voriconazole Segment by Application 1.3.1 Voriconazole Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Global Voriconazole Market Size Estimates and Forecasts 1.4.1 Global Voriconazole Revenue 2015-2026 1.4.2 Global Voriconazole Sales 2015-2026 1.4.3 Voriconazole Market Size by Region: 2020 Versus 2026 1.5 Voriconazole Industry 1.6 Voriconazole Market Trends 2 Global Voriconazole Market Competition by Manufacturers 2.1 Global Voriconazole Sales Market Share by Manufacturers (2015-2020) 2.2 Global Voriconazole Revenue Share by Manufacturers (2015-2020) 2.3 Global Voriconazole Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Voriconazole Manufacturing Sites, Area Served, Product Type 2.5 Voriconazole Market Competitive Situation and Trends 2.5.1 Voriconazole Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Voriconazole Players (Opinion Leaders) 3 Voriconazole Retrospective Market Scenario by Region 3.1 Global Voriconazole Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Voriconazole Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Voriconazole Market Facts & Figures by Country 3.3.1 North America Voriconazole Sales by Country 3.3.2 North America Voriconazole Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Voriconazole Market Facts & Figures by Country 3.4.1 Europe Voriconazole Sales by Country 3.4.2 Europe Voriconazole Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Voriconazole Market Facts & Figures by Region 3.5.1 Asia Pacific Voriconazole Sales by Region 3.5.2 Asia Pacific Voriconazole Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Voriconazole Market Facts & Figures by Country 3.6.1 Latin America Voriconazole Sales by Country 3.6.2 Latin America Voriconazole Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Voriconazole Market Facts & Figures by Country 3.7.1 Middle East and Africa Voriconazole Sales by Country 3.7.2 Middle East and Africa Voriconazole Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Voriconazole Historic Market Analysis by Type 4.1 Global Voriconazole Sales Market Share by Type (2015-2020) 4.2 Global Voriconazole Revenue Market Share by Type (2015-2020) 4.3 Global Voriconazole Price Market Share by Type (2015-2020) 4.4 Global Voriconazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Voriconazole Historic Market Analysis by Application 5.1 Global Voriconazole Sales Market Share by Application (2015-2020) 5.2 Global Voriconazole Revenue Market Share by Application (2015-2020) 5.3 Global Voriconazole Price by Application (2015-2020) 6 Company Profiles and Key Figures in Voriconazole Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 Teva 6.2.1 Teva Corporation Information 6.2.2 Teva Description, Business Overview and Total Revenue 6.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Teva Products Offered 6.2.5 Teva Recent Development 6.3 GeneTech Pharm 6.3.1 GeneTech Pharm Corporation Information 6.3.2 GeneTech Pharm Description, Business Overview and Total Revenue 6.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.3.4 GeneTech Pharm Products Offered 6.3.5 GeneTech Pharm Recent Development 6.4 Novartis 6.4.1 Novartis Corporation Information 6.4.2 Novartis Description, Business Overview and Total Revenue 6.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Novartis Products Offered 6.4.5 Novartis Recent Development 6.5 Mylan 6.5.1 Mylan Corporation Information 6.5.2 Mylan Description, Business Overview and Total Revenue 6.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Mylan Products Offered 6.5.5 Mylan Recent Development 6.6 Squibb 6.6.1 Squibb Corporation Information 6.6.2 Squibb Description, Business Overview and Total Revenue 6.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Squibb Products Offered 6.6.5 Squibb Recent Development 6.7 Sandoz 6.6.1 Sandoz Corporation Information 6.6.2 Sandoz Description, Business Overview and Total Revenue 6.6.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Sandoz Products Offered 6.7.5 Sandoz Recent Development 6.8 Daiichi Sankyo 6.8.1 Daiichi Sankyo Corporation Information 6.8.2 Daiichi Sankyo Description, Business Overview and Total Revenue 6.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Daiichi Sankyo Products Offered 6.8.5 Daiichi Sankyo Recent Development 6.9 GSK 6.9.1 GSK Corporation Information 6.9.2 GSK Description, Business Overview and Total Revenue 6.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.9.4 GSK Products Offered 6.9.5 GSK Recent Development 6.10 Cilag AG 6.10.1 Cilag AG Corporation Information 6.10.2 Cilag AG Description, Business Overview and Total Revenue 6.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Cilag AG Products Offered 6.10.5 Cilag AG Recent Development 6.11 Macherey-Nagel GmbH 6.11.1 Macherey-Nagel GmbH Corporation Information 6.11.2 Macherey-Nagel GmbH Voriconazole Description, Business Overview and Total Revenue 6.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Macherey-Nagel GmbH Products Offered 6.11.5 Macherey-Nagel GmbH Recent Development 6.12 Abbott 6.12.1 Abbott Corporation Information 6.12.2 Abbott Voriconazole Description, Business Overview and Total Revenue 6.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Abbott Products Offered 6.12.5 Abbott Recent Development 6.13 Takeda 6.13.1 Takeda Corporation Information 6.13.2 Takeda Voriconazole Description, Business Overview and Total Revenue 6.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Takeda Products Offered 6.13.5 Takeda Recent Development 6.14 Sichuan Beauty Sport Huakang Pharmaceutical 6.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Corporation Information 6.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Description, Business Overview and Total Revenue 6.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Products Offered 6.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development 6.15 Jincheng HEALTH Pharmaceutical 6.15.1 Jincheng HEALTH Pharmaceutical Corporation Information 6.15.2 Jincheng HEALTH Pharmaceutical Voriconazole Description, Business Overview and Total Revenue 6.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Jincheng HEALTH Pharmaceutical Products Offered 6.15.5 Jincheng HEALTH Pharmaceutical Recent Development 6.16 Ebang Pharmaceutical 6.16.1 Ebang Pharmaceutical Corporation Information 6.16.2 Ebang Pharmaceutical Voriconazole Description, Business Overview and Total Revenue 6.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Ebang Pharmaceutical Products Offered 6.16.5 Ebang Pharmaceutical Recent Development 6.17 Aditya Pharma 6.17.1 Aditya Pharma Corporation Information 6.17.2 Aditya Pharma Voriconazole Description, Business Overview and Total Revenue 6.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Aditya Pharma Products Offered 6.17.5 Aditya Pharma Recent Development 6.18 Taj Pharmaceuticals 6.18.1 Taj Pharmaceuticals Corporation Information 6.18.2 Taj Pharmaceuticals Voriconazole Description, Business Overview and Total Revenue 6.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2015-2020) 6.18.4 Taj Pharmaceuticals Products Offered 6.18.5 Taj Pharmaceuticals Recent Development 7 Voriconazole Manufacturing Cost Analysis 7.1 Voriconazole Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Voriconazole 7.4 Voriconazole Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Voriconazole Distributors List 8.3 Voriconazole Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Voriconazole Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Voriconazole by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Voriconazole by Type (2021-2026) 10.2 Voriconazole Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Voriconazole by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Voriconazole by Application (2021-2026) 10.3 Voriconazole Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Voriconazole by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Voriconazole by Region (2021-2026) 10.4 North America Voriconazole Estimates and Projections (2021-2026) 10.5 Europe Voriconazole Estimates and Projections (2021-2026) 10.6 Asia Pacific Voriconazole Estimates and Projections (2021-2026) 10.7 Latin America Voriconazole Estimates and Projections (2021-2026) 10.8 Middle East and Africa Voriconazole Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Voriconazole Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Voriconazole Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Voriconazole Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Voriconazole Manufacturers Covered in This Study Table 5. Global Voriconazole Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Voriconazole Sales Share by Manufacturers (2015-2020) Table 7. Global Voriconazole Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Voriconazole Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Voriconazole Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Voriconazole Sales Sites and Area Served Table 11. Manufacturers Voriconazole Product Types Table 12. Global Voriconazole Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Voriconazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Voriconazole as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Voriconazole Players Table 16. Global Voriconazole Sales (K MT) by Region (2015-2020) Table 17. Global Voriconazole Sales Market Share by Region (2015-2020) Table 18. Global Voriconazole Revenue (Million US$) by Region (2015-2020) Table 19. Global Voriconazole Revenue Market Share by Region (2015-2020) Table 20. North America Voriconazole Sales by Country (2015-2020) (K MT) Table 21. North America Voriconazole Sales Market Share by Country (2015-2020) Table 22. North America Voriconazole Revenue by Country (2015-2020) (US$ Million) Table 23. North America Voriconazole Revenue Market Share by Country (2015-2020) Table 24. Europe Voriconazole Sales by Country (2015-2020) (K MT) Table 25. Europe Voriconazole Sales Market Share by Country (2015-2020) Table 26. Europe Voriconazole Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Voriconazole Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Voriconazole Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Voriconazole Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Voriconazole Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Voriconazole Revenue Market Share by Region (2015-2020) Table 32. Latin America Voriconazole Sales by Country (2015-2020) (K MT) Table 33. Latin America Voriconazole Sales Market Share by Country (2015-2020) Table 34. Latin America Voriconazole Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Voriconazole Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Voriconazole Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Voriconazole Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Voriconazole Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Voriconazole Revenue Market Share by Country (2015-2020) Table 40. Global Voriconazole Sales (K MT) by Type (2015-2020) Table 41. Global Voriconazole Sales Share by Type (2015-2020) Table 42. Global Voriconazole Revenue (Million US$) by Type (2015-2020) Table 43. Global Voriconazole Revenue Share by Type (2015-2020) Table 44. Global Voriconazole Price (USD/MT) by Type (2015-2020) Table 45. Global Voriconazole Sales (K MT) by Application (2015-2020) Table 46. Global Voriconazole Sales Market Share by Application (2015-2020) Table 47. Global Voriconazole Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Voriconazole Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Teva Voriconazole Corporation Information Table 54. Teva Corporation Information Table 55. Teva Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Teva Main Product Table 57. Teva Recent Development Table 58. GeneTech Pharm Voriconazole Corporation Information Table 59. GeneTech Pharm Corporation Information Table 60. GeneTech Pharm Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. GeneTech Pharm Main Product Table 62. GeneTech Pharm Recent Development Table 63. Novartis Voriconazole Corporation Information Table 64. Novartis Corporation Information Table 65. Novartis Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Novartis Main Product Table 67. Novartis Recent Development Table 68. Mylan Voriconazole Corporation Information Table 69. Mylan Corporation Information Table 70. Mylan Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Mylan Main Product Table 72. Mylan Recent Development Table 73. Squibb Voriconazole Corporation Information Table 74. Squibb Corporation Information Table 75. Squibb Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Squibb Main Product Table 77. Squibb Recent Development Table 78. Sandoz Voriconazole Corporation Information Table 79. Sandoz Corporation Information Table 80. Sandoz Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Sandoz Main Product Table 82. Sandoz Recent Development Table 83. Daiichi Sankyo Voriconazole Corporation Information Table 84. Daiichi Sankyo Corporation Information Table 85. Daiichi Sankyo Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Daiichi Sankyo Main Product Table 87. Daiichi Sankyo Recent Development Table 88. GSK Voriconazole Corporation Information Table 89. GSK Corporation Information Table 90. GSK Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. GSK Main Product Table 92. GSK Recent Development Table 93. Cilag AG Voriconazole Corporation Information Table 94. Cilag AG Corporation Information Table 95. Cilag AG Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Cilag AG Main Product Table 97. Cilag AG Recent Development Table 98. Macherey-Nagel GmbH Voriconazole Corporation Information Table 99. Macherey-Nagel GmbH Corporation Information Table 100. Macherey-Nagel GmbH Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Macherey-Nagel GmbH Main Product Table 102. Macherey-Nagel GmbH Recent Development Table 103. Abbott Voriconazole Corporation Information Table 104. Abbott Corporation Information Table 105. Abbott Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Abbott Main Product Table 107. Abbott Recent Development Table 108. Takeda Voriconazole Corporation Information Table 109. Takeda Corporation Information Table 110. Takeda Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Takeda Main Product Table 112. Takeda Recent Development Table 113. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Corporation Information Table 114. Sichuan Beauty Sport Huakang Pharmaceutical Corporation Information Table 115. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. Sichuan Beauty Sport Huakang Pharmaceutical Main Product Table 117. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development Table 118. Jincheng HEALTH Pharmaceutical Voriconazole Corporation Information Table 119. Jincheng HEALTH Pharmaceutical Corporation Information Table 120. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 121. Jincheng HEALTH Pharmaceutical Main Product Table 122. Jincheng HEALTH Pharmaceutical Recent Development Table 123. Ebang Pharmaceutical Voriconazole Corporation Information Table 124. Ebang Pharmaceutical Corporation Information Table 125. Ebang Pharmaceutical Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 126. Ebang Pharmaceutical Main Product Table 127. Ebang Pharmaceutical Recent Development Table 128. Aditya Pharma Voriconazole Corporation Information Table 129. Aditya Pharma Corporation Information Table 130. Aditya Pharma Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 131. Aditya Pharma Main Product Table 132. Aditya Pharma Recent Development Table 133. Taj Pharmaceuticals Voriconazole Corporation Information Table 134. Taj Pharmaceuticals Corporation Information Table 135. Taj Pharmaceuticals Voriconazole Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 136. Taj Pharmaceuticals Main Product Table 137. Taj Pharmaceuticals Recent Development Table 138. Sales Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Voriconazole Distributors List Table 141. Voriconazole Customers List Table 142. Market Key Trends Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 144. Key Challenges Table 145. Global Voriconazole Sales (K MT) Forecast by Type (2021-2026) Table 146. Global Voriconazole Sales Market Share Forecast by Type (2021-2026) Table 147. Global Voriconazole Revenue (Million US$) Forecast by Type (2021-2026) Table 148. Global Voriconazole Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 149. Global Voriconazole Sales (K MT) Forecast by Application (2021-2026) Table 150. Global Voriconazole Revenue (Million US$) Forecast by Application (2021-2026) Table 151. Global Voriconazole Sales (K MT) Forecast by Region (2021-2026) Table 152. Global Voriconazole Sales Market Share Forecast by Region (2021-2026) Table 153. Global Voriconazole Revenue Forecast by Region (2021-2026) (US$ Million) Table 154. Global Voriconazole Revenue Market Share Forecast by Region (2021-2026) Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Voriconazole Figure 2. Global Voriconazole Sales Market Share by Type: 2020 VS 2026 Figure 3. Injection Product Picture Figure 4. Freeze-dried Powder Product Picture Figure 5. Global Voriconazole Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Figure 7. Clinic Figure 8. Other Figure 9. Global Voriconazole Market Size 2015-2026 (US$ Million) Figure 10. Global Voriconazole Sales Capacity (K MT) (2015-2026) Figure 11. Global Voriconazole Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Voriconazole Sales Share by Manufacturers in 2020 Figure 13. Global Voriconazole Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Voriconazole Revenue in 2019 Figure 15. Voriconazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Voriconazole Sales Market Share by Region (2015-2020) Figure 17. Global Voriconazole Sales Market Share by Region in 2019 Figure 18. Global Voriconazole Revenue Market Share by Region (2015-2020) Figure 19. Global Voriconazole Revenue Market Share by Region in 2019 Figure 20. North America Voriconazole Sales Market Share by Country in 2019 Figure 21. North America Voriconazole Revenue Market Share by Country in 2019 Figure 22. U.S. Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 23. U.S. Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 25. Canada Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Voriconazole Sales Market Share by Country in 2019 Figure 27. Europe Voriconazole Revenue Market Share by Country in 2019 Figure 28. Germany Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 29. Germany Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 31. France Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 33. U.K. Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 35. Italy Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 37. Russia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Voriconazole Sales Market Share by Region in 2019 Figure 39. Asia Pacific Voriconazole Revenue Market Share by Region in 2019 Figure 40. China Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 41. China Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 43. Japan Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 45. South Korea Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 47. India Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 49. Australia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 51. Taiwan Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 53. Indonesia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 55. Thailand Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 57. Malaysia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 59. Philippines Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 61. Vietnam Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Voriconazole Sales Market Share by Country in 2019 Figure 63. Latin America Voriconazole Revenue Market Share by Country in 2019 Figure 64. Mexico Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 65. Mexico Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 67. Brazil Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 69. Argentina Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Voriconazole Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Voriconazole Revenue Market Share by Country in 2019 Figure 72. Turkey Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 73. Turkey Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 75. Saudi Arabia Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Voriconazole Sales Growth Rate (2015-2020) (K MT) Figure 77. U.A.E Voriconazole Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Voriconazole by Type (2015-2020) Figure 79. Sales Market Share of Voriconazole by Type in 2019 Figure 80. Revenue Share of Voriconazole by Type (2015-2020) Figure 81. Revenue Market Share of Voriconazole by Type in 2019 Figure 82. Global Voriconazole Sales Growth by Type (2015-2020) (K MT) Figure 83. Global Voriconazole Sales Market Share by Application (2015-2020) Figure 84. Global Voriconazole Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Voriconazole by Application (2015-2020) Figure 86. Global Revenue Share of Voriconazole by Application in 2020 Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. GeneTech Pharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Cilag AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Macherey-Nagel GmbH Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Sichuan Beauty Sport Huakang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Jincheng HEALTH Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Ebang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Aditya Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Price Trend of Key Raw Materials Figure 106. Manufacturing Cost Structure of Voriconazole Figure 107. Manufacturing Process Analysis of Voriconazole Figure 108. Voriconazole Industrial Chain Analysis Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Porter's Five Forces Analysis Figure 112. North America Voriconazole Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. North America Voriconazole Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Europe Voriconazole Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Europe Voriconazole Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Latin America Voriconazole Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Latin America Voriconazole Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Middle East and Africa Voriconazole Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. Middle East and Africa Voriconazole Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Asia Pacific Voriconazole Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 121. Asia Pacific Voriconazole Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Bottom-up and Top-down Approaches for This Report Figure 123. Data Triangulation Figure 124. Key Executives Interviewed

Pfizer Teva GeneTech Pharm Novartis Mylan Squibb Sandoz Daiichi Sankyo GSK Cilag AG Macherey-Nagel GmbH Abbott Takeda Sichuan Beauty Sport Huakang Pharmaceutical Jincheng HEALTH Pharmaceutical Ebang Pharmaceutical Aditya Pharma Taj Pharmaceuticals